Standing Tall (Yima Nkqo)
1 other identifier
interventional
100
2 countries
3
Brief Summary
The investigators propose the Standing Tall study, a prospective randomised study of strategy to optimize community-based ART initiation in South Africa. Investigators will work closely with community members to integrate community-based ART. One hundred participants will be enrolled and followed for a total of up to 6 months. Those in the intervention arm will be provided with the ST intervention which includes a behavioral component and access to ART. The intervention will be linked to a clinic through a "Nurse Initiated Management of ART."
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2 hiv
Started Nov 2020
Typical duration for phase_2 hiv
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 12, 2020
CompletedFirst Posted
Study publicly available on registry
September 29, 2020
CompletedStudy Start
First participant enrolled
November 25, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2024
CompletedMarch 18, 2024
March 1, 2024
3.3 years
August 12, 2020
March 14, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
ART Initiation
ART initiation will be assessed via a self-report measure of participants who will report whether they have or have not initiated ART.
Three Months
ART Initiation
ART initiation will also be assessed via a point-of-care diagnostic detecting Tenofovir concentrations in participants.
Three Months
ART Initiation
ART initiation will be assessed via a self-report measure of participants who will report whether they have or have not initiated ART.
Six months
ART Initiation
ART initiation will also be assessed via a point-of-care diagnostic detecting Tenofovir concentrations in participants.
Six months
Secondary Outcomes (10)
Viral Load Suppression
Six Months
Household Food Security
Six Months
Mental Health
Six Months
Substance Use
Six Months
Wellness
Six Months
- +5 more secondary outcomes
Study Arms (2)
Intervention Group Sessions
EXPERIMENTALIntervention group sessions will be delivered by lay health counselors. The sessions will reflect principles of co-learning, participatory design, and empowerment to promote engagement of young people in critical thinking and problem solving - including modeling, roleplaying, and interactive activities.
Standard of Care
NO INTERVENTIONThis is the standard of care arm. Participants newly diagnosed with HIV will get a referral to the local primary health care setting of their choice for further management, including ART.
Interventions
Participants will undergo a multi-session group intervention over the course of six months.
Eligibility Criteria
You may qualify if:
- Complete an assessment of understanding
- Provide informed consent
- Are between ages 18-24
- Present to Tutu Tester vans in Cape Town OR East London DTHF clinics (Duncan Village Day Hospital, Empilweni Gompo Health Centre, Gompo C Clinic) and test HIV+
- Are ART-naïve
- Are English or isiXhosa speakers
- Reside in the Cape Town or East London metro area
You may not qualify if:
- Are pregnant (must be referred to antenatal clinic if living with HIV)
- Test positive for tuberculosis (must be referred to clinic for TB treatment prior to ART initiation)
- Are unable to understand the process of informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brigham and Women's Hospitallead
- Desmond Tutu Health Foundationcollaborator
- University of Connecticutcollaborator
- Columbia Universitycollaborator
- Massachusetts General Hospitalcollaborator
- Harvard Medical School (HMS and HSDM)collaborator
- University of Washingtoncollaborator
Study Sites (3)
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Desmond Tutu Health Foundation
East London, Eastern Cape, South Africa
Desmond Tutu Health Foundation
Cape Town, Western Cape, South Africa
Related Publications (2)
Bondarchuk CP, Lemon T, Medina-Marino A, Rousseau E, Sindelo S, Sibanda N, Butler LM, Bekker LG, Earnshaw VA, Katz IT. A Moderated Mediation Model of HIV-Related Anticipated Stigma and Social Capital on the Relationship Between Diagnosis During the COVID-19 Pandemic and Potentially Problematic Substance Use Among Young South Africans. Int J Behav Med. 2025 Nov 18. doi: 10.1007/s12529-025-10415-5. Online ahead of print.
PMID: 41249762DERIVEDNardell MF, Sindelo S, Rousseau E, Siko N, Fuzile P, Julies R, Bassett IV, Mellins CA, Bekker LG, Butler LM, Katz IT. Development of "Yima Nkqo," a community-based, peer group intervention to support treatment initiation for young adults with HIV in South Africa. PLoS One. 2023 Jun 15;18(6):e0280895. doi: 10.1371/journal.pone.0280895. eCollection 2023.
PMID: 37319250DERIVED
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 12, 2020
First Posted
September 29, 2020
Study Start
November 25, 2020
Primary Completion
March 31, 2024
Study Completion
March 31, 2024
Last Updated
March 18, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share